Connect with us

Cannabis News

Michigan Senators Weigh Marijuana Regulatory Reform Bills To Aid Industry Reeling From New Tax Increase

Published

on

“Our members are calling on this commission to help our industry create market stability and advance thoughtful and collaborative industry planning.”

By Kyle Davidson, Michigan Advance

Almost two weeks after Michigan lawmakers took office Legislation that imposes a 24 percent tax on wholesale marijuanaMembers of the Senate Regulatory Affairs Committee heard testimony on several bills that committee chairman Jeremy Moss (D-Southfield) said were aimed at reducing the regulatory burden on the cannabis industry.

Two bills were considered Wednesday, one limiting the number of licenses for marijuana dealers and supply centers, and another aimed at cracking down on the sale of unregulated intoxicating hemp products, though Moss indicated there would be additional meetings on the bills in the future.

Sen. Sam Singh (D-East Lansing) unveiled the first package, the Senate Bills 597 and 598Starting Jan. 1, 2026, it would limit marijuana dealer licenses and wholesale licenses per 10,000 residents in a municipality, similar to how the state regulates liquor sales.

Singh said communities with a population of less than 10,000 would always have at least one license.

In addition, current license holders can renew their licenses or transfer them to another person.

Second set, Senate bills 599602It would create a regulatory framework for consumer hemp products in Michigan, Sen. Dayna Polehanki (D-Livonia) explained, citing that intoxicating products made from hemp, including Delta-8 and other synthetic cannabinoids, are being sold at Michigan gas stations, convenience stores and online without oversight or testing.

Both proposals received support from the Cannabis Regulatory Agency, which regulates Michigan’s adult cannabis industry, as well as support from several members of the state’s cannabis industry.

Derek Sova, the agency’s policy and legislative specialist, said one of the agency’s challenges is marijuana versus hemp, when debating whether a substance is intoxicating or not.

Hemp is commonly understood to be either a crop or a tissue, Sova explained, with both Michigan and the federal government’s definitions of hemp and marijuana allowing the unregulated sale of products containing high amounts of THC, the marijuana component primarily responsible for its intoxicating effect.

“Because of the way it’s defined, they’re considered hemp, and because of that, they’re not age-appropriate. There’s no testing requirement, like there is in Michigan with marijuana products. There’s no labeling restrictions,” Sova said.

In addition to establishing a regulatory framework for non-toxic consumable hemp products, such as CBD-infused gummies and intoxicating hemp products, Sova said the bill package would regulate the sale of non-consumable hemp, which is used to make textiles and building materials.

“Right now, under the current law, you have to get a license to do that, a license to sell that. We don’t think that should be regulated,” Sova said.

Robin Schneider, executive director of the Michigan Cannabis Industry Association, offered support for limiting licenses for marijuana suppliers and retailers, saying unlimited marijuana cultivation licenses have led to oversupply, lowered wholesale prices and harmed businesses throughout the supply chain.

Additionally, the proliferation of retail space has led to public nuisance concerns, traffic problems and community complaints, Schneider said.

“Our members are calling on this committee to help our industry create market stability and thoughtful, collaborative industry planning to make business decisions based on projections that at least include predictability,” Schneider said.

The association also supported the regulation of intoxicating hemp products, noting that these products are being shipped out of state to Michigan and are not being produced by Michigan hemp farmers.

“Not only have our hemp farmers been left out and harmed in many ways, current legislation does not allow them to manufacture hemp products for CBD-only consumption in Michigan,” Schneider said.

Kyleigh Cumming, lab director at Kairos Labs, a cannabis testing lab, told committee members that the 2018 farm bill defining hemp created a loophole that allowed CBD to be converted into THC-like compounds.

“These conversion processes create many dangerous and unknown byproducts along the way, while allowing the resulting products to be labeled as hemp-derived and sold in Michigan as an unregulated intoxicant,” Cumming said.

In a study of 15 vape products purchased in various southeast Michigan communities, Cumming said the products had no lab test results or traceability, and when purchasing the products, no one asked for ID to verify age. When the products were tested, the lab found 15 contaminants, and all 15 samples detected the THC levels of 0.3 percent set by the federal government.

While offering support for additional regulations on hemp products, City of Detroit cannabis director Kimberly James called for more teeth in the bill to allow local governments to take action when intoxicating hemp products are sold in unlicensed locations.

“(The Cannabis Regulatory Agency) does not currently enforce violations of the (Michigan Regulation and Marijuana Tax Act) against non-licensees, and I would not expect them to enforce violations of this act against anyone who is not a licensed consumer hemp processor,” James said. “Local governments should have the authority to stop this practice immediately when the products are in a regular store and explicitly state that they contain THC.”

Polehanki promised to work with James to make sure those changes were made, saying the legislation “isn’t good unless we take these products off the market.”

Blain Becktold, founder of iHemp Michigan, which represents hemp farmers, manufacturers and businesses across the state, said the group’s members supported denying or limiting the sale of products that could be harmful to purchase or consumption, but he refused to define hemp as hemp with less than 0.3 percent THC, pointing to a federal push to increase the 1 percent to 1 percent.

“That’s not to make more toxic products. That’s really for the safety of growers and farmers. If they invest that time, money and effort into farming, and it warms over .3, they’ve lost all of that. 1 percent we wouldn’t have that problem,” Becktold said.

Cassin Coleman of Cannabis Consumer Advocacy also expressed concern about the proposed regulations, noting that limiting THC in non-intoxicating hemp products would limit access to certain products that individuals use for medical purposes.

“As is often the case, the products that patients use consistently, which are CBD products, contain THC,” Coleman said, noting that these products contain THC because they are “full spectrum,” meaning they contain the full range of compounds that occur in the cannabis plant.

Trying to remove or limit the amount of THC in these products would remove other important cannabinoids, plant proteins and antioxidants, Coleman said, warning that these products could be ineffective.

This story was first published by the Michigan Advance.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

Vivent Biosignals & Green Laniel join forces to bring plant-driven agriculture to the US

Published

on

By











Vivent Biosignals and Green Laniel Consulting have announced a partnership to accelerate plant-driven irrigation and irrigation in key U.S. agricultural markets. Green Laniel Consulting is a US-focused provider of agronomic solutions led by Mauricio Manotas.

By combining Vivent’s ability to decode plant biosignals in real-time using plant biosensors, machine learning and AI with Green Laniel’s deep experience in agronomy, grower operations and US market access, the partnership allows growers to make decisions based on what really matters: how the plant itself is responding.

© Vivent Biosignals

The partnership will cover a variety of crops and production systems, initially plant-driven irrigation and greenhouses for perennial crops, including potatoes, directly guided by plant feedback.

“By combining Vivint’s plant-level intelligence with Green Laniel’s strong presence and agronomic leadership in the US, we are enabling a new generation of plant-driven farming systems. This partnership helps growers improve yields and quality while significantly increasing resource efficiency and sustainability.” says Mauricio Manotas, Green Laniel Consulting.

For more information:
Vivent Biosignals
Tel.: +41 79 5114627
Email: (email protected)
https://vivent-biosignals.com/



Publication date:













Continue Reading

Cannabis News

Indiana Lawmakers Approve Bill To Restrict And Regulate Hemp THC Products

Published

on

By

“In India, we would like some certainty about these products so that those who manufacture and sell them know what our laws are.”

By Leslie Bonilla Muñiz, Indiana Capital Chronicle

Indiana lawmakers want state legislation to join the recently enacted federal ban on intoxicating and synthetic hemp products to counter the growing delta-8 industry.

Lengthy and complex legislation would also regulate less potent products that pass statutory muster.

But, “there will be no demand” for products below the proposed threshold, said Justin Swanson, representing the Midwest Hemp Council and 3Chi, a THC products retailer.

THC is the active ingredient in marijuana.

Sen. Aaron Freeman, R-Indianapolis, admitted to the committee that he would prefer to “wipe all these things off the planet, period,” but that his proposal is “whatever is possible.”

His Senate Bill 250 would mimic Congress’s shutdown of what Freeman described as the “Farm Bill loophole,” referring to 2018 legislation that defined legal hemp as any part of the plant that contains less than 0.3 percent delta-9 THC by dry weight. That definition allowed products containing delta-8, THCA and other intoxicating cannabinoids to proliferate, including in Indiana.

A federal funding law passed in November specifies that all types of THC count. It also limits THC products to just 0.4 milligrams per container, and completely bans those made in labs.

“I think (that’s) what the federal government wanted when they passed the Farm Bill in 2018; I think that’s what everybody had in mind when they copied that language here in Indiana,” said Chris Daniels, chief traffic safety resource attorney for the Indiana Prosecuting Attorneys Council. “The target was very low potency THC.”

An industry group supported the changes.

“It is imperative that Indiana act to align with federal policy in the 2026 legislative session,” said Cory Harris, representative of the American Cannabis and Hemp Trade Association. “Failure to do so means that Indiana’s policy will be stricter than federal law, making Indiana a legal cannabis market.”

The federal provisions will go into effect in November. Freeman’s bill repeats those provisions, but puts them into effect four months earlier, in July.

“It’s sweet that Indiana codified a federal law that will decimate an entire industry in the state,” Swanson said. “The landscape is still unsettled.”

U.S. Rep. Jim Baird — a Republican representing Indiana — introduced a proposal to push the effective date of the federal ban to 2028. President Donald Trump also signed an executive order to expedite the reclassification of marijuana as a less dangerous and less restricted drug.

Swanson said his clients support a “responsible regulatory framework,” and told lawmakers that “the status quo is not acceptable to anyone.”

Freeman’s invoice spends dozens of pages specifically regulating low-THC “hemp-derived cannabinoid products” that would be legalized, primarily with a long-standing 21-and-over requirement.

It also puts the Indiana Alcohol and Tobacco Commission in charge of regulating the rest of the industry, establishing four types of licenses for manufacturers, distributors, retailers and carriers. They would be prohibited from advertising within 1,000 feet of schools, playgrounds and others, with retailers prohibited from operating within the same radius.

Retailers would not be able to deliver products or allow customers to consume them on the spot. Selling the products online would also be illegal, another sticking point for advocates.

Dave Colt, CEO and co-founder of Sun King Brewery, said his homegrown company spent months and more than $100,000 on equipment, research and development for its THC seltzer. Amid declining alcohol sales nationwide, seltzers have allowed Sun King to retain its employees and even grow.

“We also make products for at least a dozen Hoosier small businesses. Without that additional revenue, we would be forced to lay off people and reduce our business significantly,” Colt stated. “We believe the industry wants clear regulations to meet consumer demand.”

Other provisions relate to packaging, labeling and testing.

A fiscal impact study by the nonpartisan Service Agency estimated a financial impact of half a billion dollars annually for ATC to administer and enforce the proposal. The agency will have to hire at least one excise officer in each of the six districts plus Marion County to investigate complaints related to the new regulatory framework.

There will be additional costs for law enforcement training, procurement and online databases, the analysis noted.

The costs could be offset by the permit and other fees collected. The measure would allocate 70 percent of the proceeds to ATC administrative efforts, 20 percent to enforcement, 5 percent to the state’s 988 suicide and crisis hotline and 5 percent to the general fund.

If all tobacco sales certificate holders applied for a retail permit, for example, their application fees would generate $2.1 million. If all are approved, the state would earn an additional $4.6 million, according to LSA’s analysis.

The state seed commissioner would handle licensing for hemp growers and handlers.

Freeman also included a sentence that prevents the Indiana code from immediately reflecting the federal reclassification of marijuana, if that goes forward.

“This bill simply says that we’re not going to automatically follow what the federal government does, that we, the 150 of us, would make that decision, not the federal government for us,” Freeman told his colleagues.

The Senate Commerce and Technology committee also approved an amendment to eliminate an excise tax, as all revenue-raising provisions must be initiated in the House.

The revised legislation passed on a 7-2 party line vote, but the next bill must pass through the Senate Appropriations Committee before going to the House floor.

Previous efforts to ban and regulate intoxicating hemp products have failed.

Asked about his chances this year, Senate Republican Leader Rodric Bray told reporters, “I don’t have that crystal ball,” but added, “I think the bill is in pretty good shape right now.”

“I think in Indiana, we would like some certainty about these products, so that those who manufacture and sell them know what our laws are,” he continued, “and, most importantly, to build in some really meaningful protections for our young people across the state.”

This story was first published by the Indiana Capital Chronicle.

Brendan Cleak’s photo.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

Creating a thoughtful cannabis environment for Colorado Springs

Published

on

By

In Colorado Springs, where the landscape of legal cannabis is centered around medical use, BioMeds Weed Dispensary Colorado Springs has become a destination for patients seeking high-quality cannabis products and a fair and respectful retail experience. Located at 2301 Rand Avenue, BioMeds has developed a reputation for prioritizing product integrity, patient education and consistent service in response to the brightest trends found in recreationally oriented markets.

Unlike recreational dispensaries, where the volume and variety can sometimes overwhelm, BioMeds takes a deliberate approach. The dispensary offers a good selection of medical cannabis products, including a variety of delivery formats to suit your health needs. These typically include flower strains, tinctures, capsules, topicals, and ingestibles, allowing patients to explore therapeutic cannabis without relying on inhaled methods.

BioMeds understands that patients arrive with different experiences, preferences and conditions. To meet these needs, the dispensary emphasizes informed, non-judgmental customer service based on product knowledge. The staff is trained to explain how different formats work, as well as interpret cannabinoid ratios, identify common terpenes, and select products that match specific wellness goals.

© BioMeds Weed Dispensary Colorado Springs

BioMeds’ product selection is part of the reason patients turn to cannabis. For many, whole flower remains a must-have choice, especially strains that emphasize CBD content, balanced proportions or effect-specific terpene profiles. BioMeds often sells indica, sativa, and hybrids with specific labeling, allowing patients to make informed decisions about onset time, duration, and expected outcome. Beyond flower, tinctures and capsules offer discreet, dose-controlled ways to incorporate cannabis into your daily wellness routine, especially for those managing pain, inflammation, or neurological conditions.

Topicals are also a key part of BioMeds’ offering. These include cannabinoid-infused creams, salves, and lotions intended for topical use. Patients dealing with joint discomfort, muscle tension, or skin conditions often turn to topical products for their non-toxic effects and targeted relief. These products also serve as an entry point for patients exploring cannabis for the first time, especially when faced with systemic or psychoactive effects.

Another category that sees sustained interest in BioMeds is ingestion. These may include low-dose edibles, oils, or beverages tailored to patients seeking long-lasting, absorbed beverages. While recreational edibles in Colorado may gravitate toward high-THC formats, medically focused dispensaries like BioMeds ensure that low-dose, balanced-ratio, CBD-rich formats are available and clearly labeled. Many patients prefer longer-lasting edible formats, especially for managing symptoms at night or for relief throughout the day.

Compliance is a pillar of BioMeds’ operating philosophy. As a medical-only dispensary, the group complies with all Colorado Department of Public Health and Environment (CDPHE) guidelines. Patients must present a valid marijuana card, and all transactions are recorded and monitored according to state protocols. BioMeds does not allow recreational sales and maintains internal training programs to keep employees up-to-date on evolving regulations, labeling requirements and patient protection.

While the dispensary may not offer flashy promotions or themed events often seen in the recreational market, it has placed a special emphasis on medical integrity and personalized service in the Colorado Springs cannabis landscape. For patients who prioritize results over hype, BioMeds offers a consistent experience with proven products and a team that truly understands the nuances of using medical cannabis.

Behind the scenes, BioMeds maintains strong supplier relationships to ensure product availability and freshness. Inventory is regularly reviewed and rotated, and the team communicates directly with manufacturers to maintain transparency around sourcing, testing and packaging. The dispensary favors small and medium-sized Colorado growers who focus on consistency and compliance, with many products undergoing third-party lab testing for cannabinoid content, residual solvents and microbial contamination.

For more information:
BioMeds Weed Dispensary Colorado Springs
biomedsofcolorado.com/

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media